Literature DB >> 3569252

Multiply resistant Streptococcus mitis isolated from conjunctival exudate of newborns.

S Kontiainen, A Sivonen.   

Abstract

Streptococcus mitis resistant to most of the commonly used antimicrobial agents but sensitive to cefotaxime, clindamycin, vancomycin and rifampicin was isolated from conjunctival exudate of newborns. The isolate had group C streptococcal antigen, was beta-haemolytic on horse but alpha-haemolytic on sheep blood agar plates and might therefore be misidentified as beta-haemolytic group C streptococci.

Entities:  

Mesh:

Year:  1987        PMID: 3569252     DOI: 10.1007/bf02097192

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  6 in total

1.  Infection with minute-colony-forming beta-haemolytic streptococci.

Authors:  P M Poole; G Wilson
Journal:  J Clin Pathol       Date:  1976-08       Impact factor: 3.411

2.  Activity of nine antimicrobial agents against Lancefield group C and group G streptococci.

Authors:  K V Rolston; J L LeFrock; R F Schell
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

3.  Antimicrobial tolerance in group C and group G streptococci.

Authors:  K V Rolston; P H Chandrasekar; J L LeFrock
Journal:  J Antimicrob Chemother       Date:  1984-04       Impact factor: 5.790

4.  Multiply resistant viridans streptococci: susceptibility to beta-lactam antibiotics and comparison of penicillin-binding protein patterns.

Authors:  B F Farber; G M Eliopoulos; J I Ward; K L Ruoff; V Syriopoulou; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

5.  Physiological differentiation of viridans streptococci.

Authors:  R R Facklam
Journal:  J Clin Microbiol       Date:  1977-02       Impact factor: 5.948

6.  Ophthalmia neonatorum in the 1980s: incidence, aetiology and treatment.

Authors:  J M Pierce; M E Ward; D V Seal
Journal:  Br J Ophthalmol       Date:  1982-11       Impact factor: 4.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.